[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
CEO, Council for Healthcare Leadership
Denver, CO
Idahlynn has spent her career as a professor, leader, administrator, speaker, consultant, and coach. She has had an award-winning professional career as a university professor, scholar, and leader. For the past 30 years she has devoted her time and energy to professional speaking, writing, executive coaching, and consulting for healthcare, higher education, business, and professional associations in the US, Canada, Ireland, UK, Europe, Asia, China, and Australia. Her professional goal is to facilitate excellence in personal and professional growth by creating and facilitating innovative and highly interactive learning environments and opportunities for professionals and to develop knowledge, skill, and capacity for positive learning outcomes and achievement of excellence for individuals, teams, and organizations.
Dr. Karre (PhD. University of Colorado, 1975) has been recognized for excellence in teaching, speaking, research, and leadership. Repeatedly chosen as Favorite Professor by her university students (1969-2002), recognized as University Scholar, Woman of the Year, National Teacher of the Year (1992), International Leader of the Year (2000), Gallup Vision Award (2008), numerous citations from the Fortune 1000, and in 2011 honored by the International Leadership Academy as they named their annual award for leadership excellence in her name.
For over 50 years, Idahlynn has enjoyed designing and facilitating multi-session professional development management and leadership training for higher education and healthcare organizations. Her current clients include: The Society for Maternal Fetal Medicine; Sera Prognostics International Women’s Healthcare; HERA Women’s Health; State Colleges and Universities of New York, PEAKS (A Collaborative of New York Community Colleges), Harvard Medical School, Community Colleges of Minnesota, South Dakota School of Mines, University of Houston, University of California College and Universities, Colleges and Universities of Nova Scotia, Khesar Gyalpo University of Medical Sciences of Bhutan, National Maternity Hospital Dublin Ireland, Columbia University Medical School, New York City Mount Sinai Healthcare System, American College of Obstetrics and Gynecology, Association of Professors of Gynecology and Obstetrics, Obstetrics and Neonatal Nurses; Banner Health, and others.
As a contributor to professional publications her scholarship and authorship focuses on strengths-based leadership; positive psychology; creating and sustaining effective interpersonal relationships; building and coaching high performance teams; leading with influence; creating cultures of excellence; servant leadership; engaging in conversation that matter for personal, professional, and organization growth; feedback, crucial conversations, talent management, and professional accountability. She is a certified trainer with the Gallup Organization, StrengthsQuest, Crucial Learning (formerly VitalSmarts), DiSC, and Emotional Intelligence 2.0.
Register via Zoom for those not able to attend in person
Learn more about the Eleanor Delfs Lectureship for Pioneers[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
The Annual Women’s Health Conference is a one-day CME accredited program through MCW, ACOG and AAFP, providing up-to-date information in all aspects of Women’s Health and medical updates in General OBGYN and subspecialties. While most conferences focus on the needs of our patients, we have taken an active approach to incorporate provider wellness. In recent years, we have featured topics such as provider burnout, self-care, and second victim. Some of our most popular topics have included contraception, sexual dysfunction and menopause.
[/vc_column_text][vc_separator type=”normal” thickness=”3″][vc_column_text css=”.vc_custom_1675263419886{background-color: #f9f9f9 !important;}”]
[/vc_column_text][vc_empty_space height=”12px”][vc_column_text]
[/vc_column_text][vc_column_text]
Educates women through consumer publications, media appearances, and writing books, such as:
[/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
[/vc_column_text][vc_empty_space height=”20px”][vc_column_text]
[/vc_column_text][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Learn more about the conference
[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Victor Jin, PhD
Linda T. and John A. Mellowes Endowed Chair of Bioinformatics and Data Analytics
Director, Bioinformatics Shared Resources
Professor, Institute for Health and Equity/Biostatistics
Medical College of Wisconsin
Dr. Jin has extensive experience in developing computational and genomics approaches for analyzing various omics-seq data, and runs a systems biology lab with a balanced dry and wet components.
1) Developing genomics and computational approaches for the identification of three-dimensional (3D) chromatin interactions from the various omics-seq data.
2) Functionally and mechanistically characterizing the roles of epigenetic marks in cancer development and progression using novel techniques such as 3C/ChIP/RT-qPCR, 3D-FISH and CRISPR/Cas9.
3) Adapting/applying genome-wide omics-seq techniques in patient tissues to identify epigenetic-driven therapeutic targets and biomarkers.
Learn more about the WHRP Seminars[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Serena H. Chan, MD, FACOG, is Chief of the Pediatric & Adolescent Gynecology division at UPMC Children’s Hospital of Pittsburgh. She is also an Assistant Professor of Obstetrics, Gynecology & Reproductive Sciences at the University of Pittsburgh School of Medicine. She is board-certified in obstetrics and gynecology by the American Board of Obstetrics and Gynecology.
Dr. Chan earned her Medical Degree from Oregon Health and Science University before completing her Residency in Obstetrics and Gynecology at UPMC Magee-Womens Hospital. She also completed a Fellowship in Pediatric and Adolescent Gynecology Fellowship at Cincinnati Children’s Hospital.
Dr. Chan’s clinical specialties include medical and surgical management of pediatric and adolescent gynecologic concerns, congenital abnormalities of the female reproductive tract, and fertility preservation and reproductive endocrine issues in girls undergoing gonadotoxic therapy. Her research interests include gynecological concerns in females with anorectal malformations, trainee education in provision of adolescent reproduction health services. She has published and presented on the topics of surgical management of reproductive tract anomalies, fertility preservation, and gynecologic concerns in adolescent/young adult cancer survivors. She is a member of the North American Society for Pediatric/Adolescent Gynecology (NASPAG), the American Society for Reproductive Medicine (ASRM), the American Association of Gynecologic Laparoscopists (AAGL), and the American College of Obstetricians and Gynecologists (ACOG).
Register via Zoom for those not able to attend in person
Learn more about the E. James Aiman, MD, Endowed Lectureship[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]Resident and Fellow Research and Alumni Day is an annual event where our residents and graduating fellow present their clinical, translational science, and educational research results within their residency and fellowship in the Department of Obstetrics and Gynecology.[/vc_column_text][vc_separator type=”normal” thickness=”3″][vc_empty_space height=”20px”][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column width=”1/2″][vc_column_text]You must register for this in-person event:[/vc_column_text][vc_empty_space height=”12px”][/vc_column][vc_column width=”1/2″]Register Now![/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_separator type=”normal” thickness=”3″][vc_column_text]
[/vc_column_text][vc_column_text]
Time | Activity |
---|---|
7:15am | BREAKFAST |
7:45am | WELCOME & INTRODUCTIONS |
8:00am | Yiwen Cui, MD, MFM Fellow O-GlcNAc transferase contributes to sex-specific placental deregulation in gestational diabetes Mentor: Stephanie Olivier-Van Stichelen, PhD |
8:15am | Lindsay McAlarnen, MD GYN ONC Fellow Exosomal FXR1 as a translational mediator in the ovarian cancer microenvironment Mentor:Pradeep Chaluvally-Raghavan, PhD |
8:30am | Rebekah Summey, MD GYN ONC Fellow Exploration and exploitation of hormonal pathways in adult granulosa cell tumors for development of targeted therapeutics Mentors: Elizabeth Hopp, MD and Janet S. Rader, MD |
8:45am | Alex Levy, MD, R4 Is One Superior? Comparison of Early Removal Rates of Intrauterine Device versus Nexplanon Subdermal Implant in Women Ages 16-24 in Milwaukee, Wisconsin Mentor: Jessica Francis, MD |
9:00am | Rana Aliani, MD R3 Impact of Race, Insurance, and Procedural Timing on Sterilization Method Mentor: Ben Beran, MD |
9:15am | Mary Siracusa, MD R3 Determining Patients’ Preferred Ultrasound Provider During the Preoperative Evaluation of Endometriosis Mentor: Ben Beran, MD |
9:30am | BREAK |
9:45am | Iman Khan, MD R3 Postpartum Care in a Post-COVID Era Mentors: Amy Domeyer, MD and Erika Peterson, MD |
10:00am | Blake Neuburg, MD R3 Inpatient Versus Outpatient Management of Gestational Hypertension or Preeclampsia Without Severe Features Mentor: Anna Palatnik, MD |
10:15am | Ankita Sarawagi, MD R3 Screening rates for intimate partner violence (IPV) in the OBGYN clinic from 2019 to 2022 Mentor: Kim Gecsi, MD |
10:30am | Margaret Bruce, MD R3 Evaluating Modern Contraceptive Methods as Risk Factors for Recurrent UTI’s Mentor: Sumana Koduri, MD |
10:45am | BREAK |
11:00am | The Roland S. Cron Lecture: Nandini Raghuraman, MD, MS Fellowship Program Director, Maternal-Fetal Medicine Assistant Professor, OB/GYN Washington University School of Medicine "Moving Evidence into Clinical Practice on Labor & Delivery" |
12:00pm | Questions for Dr. Raghuraman |
12:30pm | Lunch |
Nandini Raghuraman, MD MSCI
Fellowship Program Director, Maternal-Fetal Medicine
Assistant Professor, OB/GYN
Washington University School of Medicine
Nandini Raghuraman, MD, MSCI, is an Assistant Professor in the Division of Maternal-Fetal Medicine at Washington University in St Louis and the MFM Fellowship Program Director. She is a NIH-funded physician scientist with expertise in Labor & Delivery clinical trials and implementation science in obstetrics. She has authored over 70 peer reviewed manuscripts and is currently leading a multicenter randomized trial investigating the effect of maternal oxygen supplementation in labor for fetal resuscitation.
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Wei Xu, PhD
Professor of Oncology, Marian A. Messerschmidt
Associate Director,, McArdle Laboratory for Cancer Research
Director of MCW Tissue Bank
Co-Director, Genetic and Epigenetic Mechanism Program, Carbone Cancer Center
Dr. Xu’s laboratory explores the protective roles of environmental and nutritional estrogenic compounds in mammals for breast cancer prevention and treatment. Estrogen receptors (ERs) exist in two forms, ERa and ERb, which have opposing roles in cell proliferation. Estrogenic compounds can control balance between mammary cell proliferation and differentiation via stimulating the formation of different forms of ER dimers. Xu lab has developed the Bioluminescent Resonance Energy Transfer (BRET) assays for detecting in vivo homodimerization and heterodimerization of ERa and ERb induced by estrogenic compounds. Biological functions of these estrogenic compounds are currently being investigated in cell-based and breast cancer mouse models. Dr. Xu’s laboratory has also employed biochemical and functional genomic approaches, as well as mouse genetics to decipher the contribution of histone arginine methylation to the epigenetic control of cancer cells. The major focus of Xu lab is on a protein arginine (R) methyltransferase CARM1/PRMT4, a nuclear hormone receptor co-activator. Dr. Xu has identified a number of non-histone substrates for CARM1 and is in the progress of elucidating the functions of protein arginine methylation in breast cancer initiation and progression.
Learn more about the WHRP Seminars[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Professor, Pediatric Surgery, Surgery
University of Michigan Health
George B. Mychaliska, M.D. is the Robert Bartlett, MD Collegiate Professor of Pediatric Surgery and a Professor of Obstetrics and Gynecology at the University of Michigan. He earned his Medical Degree and Master’s of Science from the Joint Medical Program at the University of California at San Francisco and Berkeley. He completed his General Surgery residency and Fetal Surgery fellowship at UCSF. Dr. Mychaliska completed his Pediatric Surgery fellowship at the Children’s Hospital of Michigan. He is board certified in Pediatric Surgery and General Surgery. Dr. Mychaliska’s practice encompasses all aspects of pediatric surgery. His clinical areas of interest and expertise are prenatal diagnosis and fetal surgery. Dr. Mychaliska’s research interests include prenatal diagnosis and therapy, pulmonary development, and congenital diaphragmatic hernia.[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Bo Wang, PhD
Director – Tissue Regenerative Engineering Laboratory (TRE Lab)
Assistant Professor – Department of Biomedical Engineering, The Marquette University and Medical College of Wisconsin
Dr. Bo Wang, Director and Principal Investigator of the TRE Lab, received her PhD in Biomedical Engineering from Mississippi State University in 2012 and completed her Postdoctoral Fellowship at Northwestern University’s Feinberg School of Medicine, Department of Surgery, in 2016. She joined the Marquette-MCW Joint Department of Biomedical Engineering in January of 2019 with research interests that include stem cell engineering, hard-tissue engineering and 3D bioprinting, as well as vascular tissue engineering, imaging, modeling and simulation.
The Tissue Regenerative Engineering Laboratory is developing bio-functional engineered tissues that provide advanced therapeutic options for such conditions as birth defects, bone disorders, and liver and vascular diseases. To do this, the TRE Lab will first develop a greater understanding of the biological and molecular processes involved in regenerative regression.
Learn more about the WHRP Seminars[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation. Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course– from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.
Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.
[/vc_column_text][vc_column_text]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=””][vc_column][vc_column_text]
Navonil De Sarkar, PhD
Assistant Professor – Department of Pathology at the Medical College of Wisconsin
Navonil De Sarkar is an Assistant Professor at the Medical College of Wisconsin Cancer Center with a dual background in computational and experimental genomics; he brings a multidisciplinary approach to studying human cancers. His research focuses on understanding the natural history of the disease, devising noninvasive approaches to track adaptive and molecular evolutionary changes in cancer accurately, and ultimately developing practical strategies for precision medicine in advanced cancer patients (Augmented precision medicine).
Navonil received his Ph.D. from the Indian Statistical Institute and joined Peter Nelson’s lab at the University of Washington & Fred Hutchinson Cancer Research Center, Seattle, for postdoctoral training. Through adopting integrative genomics approaches, Navonil developed extensive experience analyzing tumor genomes to study functionally relevant mutations and structural aberrations using tumor tissue and circulating tumor DNA (ctDNA). Navonil participated in several large-scale consortium data analyses, including Stat-up-to-cancer germline and prostate tumor analysis efforts. Navonil led the bioinformatics analysis of the large-scale germline sequence work that highlighted the importance of inherited DNA repair genes in shaping the fate of advanced prostate cancer. He is one of the early discoverers of CDK12 loss-associated tandem duplicator signature. Subsequently, De Sarkar developed a machine learning-based classifier that accurately predicts functional homologous recombination deficiency. Recently, he co-led a study interrogating whole genomes of advanced prostate cancers using cell-free DNA sequencing and discovered imprints of cancer epigenomes in native cell-free DNA sequence data.
Navonil is a recipient of several trainee awards. To mention in 2019 Navonil received the very competitive Prostate Cancer Foundation Young Investigator Award. Then onwards, Navonil is co-leading Prostate Cancer Foundation DNA repair-focused working group activities. He is the editorial board member for Translational Oncology and an associate editor for the Genitourinary Oncology edition of Frontiers journals.
Navonil re-joined MCW in March 2023 and committed to establishing a multidisciplinary research group to develop cutting-edge but practical precision medicine tools for prostate and other cancers. Building on strong biological fundamentals and detailed understandings of the disease, De Sarkar Lab (DeTAnomics Lab) is developing novel therapeutic strategies and working to co-develop new genomic assays and computational genomics tools to help us tackle the most lethal types of prostate and other cancers. DeTAnomics Lab adopts long-read genomic sequencing techniques to better understand cancer genome, transcriptome, and epigenome. In the lab, DeTAnomics lab explores the complex interplay between the genome and epigenome to uncover new insights that can lead to the development of more effective therapeutics and biomarkers. Currently, DeSarkar and his team are working on developing a practical strategy to degrade BRCA2 in tumor cells so as to confer DNA-damaging mediated therapy benefits to a wider pool of patients.
Learn more about the WHRP Seminars[/vc_column_text][/vc_column][/vc_row]
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text]
Sloane L. York, MD MPH, (she/her), is currently an Associate Professor of Obstetrics and Gynecology division of Complex Family Planning at Rush University Medical Center in Chicago, IL. She completed her residency in OBGYN in 2011 and Family Planning Fellowship in 2013 at Northwestern University, where she also received a Masters in Public Health. Dr. York joined the faculty at Rush in 2013 where she established family planning services and helped develop the Division of Family Planning. Since 2018, she has been the OBGYN Residency Program Director at Rush. Dr. York is also the Associate Program Director for the Complex Family Planning Fellowship at Rush which began in 2022. Additionally, she works as an OB Hospitalist at Rush and is a mom to two very active children.
Learn more about the E. James Aiman, MD, Endowed Lectureship[/vc_column_text][/vc_column][/vc_row]